Purdue Pharma and states agree to $4.5 billion OxyContin settlement

Published



Purdue Pharma, the maker of OxyContin, has reached an agreement with 15 states that could lead to a $4.5 billion settlement for opioid cases.

Purdue and the family that owns it, the Sacklers, are accused of engaging in illegal activities to boost the sales of OxyContin, a prescription opioid. Over 500,000 people have died from opioid overdoses in the United States.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.